Retatrutide is best kept in its lyophilised form at 20C or lower, ideally in a freezer
Retatrutide is an investigational compound not approved for human use by the FDA or Health Canada
In 2021, it was recorded that around 11.6% of the population had diabetes and around 304,000 children and adolescents also suffered from it
Next came tirzepatide (Zepbound and Mounjaro), which acts on GLP-1 as well as GIP (glucose-dependent insulinotropic polypeptide), a second gut hormone
Recent innovations, such as new subcutaneous injection devices and inhalable formulations, cater to patient preferences for convenience and needle-free options
Improves Sleep: Many users report improved sleep quality, likely due to the increased endorphin levels that also help regulate the sleep cycle